Relay Therapeutics
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-1.17-1.28-1.45-1.82
Price/Sales ratio
54.738.897.542.77
Earnings per Share (EPS)
$-2.88$-2.65$-2.34$-1.86

Historical Multiples (2018 – 2023)

2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.78-2.25-36.13-5.88-6.59-3.94-6.96-36.13
Price/Sales ratio
N/AN/A21.42964.551.21K52.821.46K21.42
Price/Book Value ratio
-0.78-0.832.323.251.761.792.123.25
Price/Cash Flow ratio
-1.97-2.26-17.28-39.26-7.30-4.49-8.81-17.28
Price/Free Cash Flow ratio
-1.90-2.02-16.96-37.51-7.02-4.43-8.47-16.96
Price/Earnings Growth ratio
N/A0.100.39-0.010.11-0.17-0.19-0.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A95.70%-29.58%-199.05%79.37%26.43%26.43%
Operating Profit Margin
N/AN/A-67.50%-12040.21%-21670.89%-1460.11%-21670.89%-12040.21%
Pretax Profit Margin
N/AN/A-63.41%-12012.94%-21036.13%-1338.65%-21036.13%-12012.94%
Net Profit Margin
N/AN/A-59.29%-16401.71%-18411.22%-1338.65%-21036.13%-16401.71%
Effective Tax Rate
-2.26%11.68%6.48%-36.53%12.47%N/AN/A-36.53%
Return on Assets
-11.38%-16.91%-6.12%-49.26%-23.11%-40.51%-26.41%-49.26%
Return On Equity
43.97%36.85%-6.42%-55.33%-26.75%-45.47%-32.53%-55.33%
Return on Capital Employed
-11.82%-22.05%-7.09%-37.05%-28.88%-45.83%-28.88%-37.05%
Liquidity Ratios
Current Ratio
N/AN/A56.49N/AN/AN/A16.00N/A
Quick Ratio
61.7730.0773.9568.2015.8125.4415.6868.20
Cash ratio
61.393.5032.8339.3915.674.742.3839.39
Days of Sales Outstanding
N/AN/A365595.271.37KN/A80.87595.27
Days of Inventory outstanding
N/AN/A-24.48K-63.46K1.07KN/AN/A-24.48K
Operating Cycle
N/AN/A-24.11K-62.87K2.44KN/AN/A-24.11K
Days of Payables Outstanding
797.27896.91653.17769.61934.85638.07N/A769.61
Cash Conversion Cycle
N/AN/A-24.77K-63.64K1.51K-638.07N/A-24.77K
Debt Ratios
Debt Ratio
N/AN/A0.000.000.000.000.130.00
Debt Equity Ratio
N/AN/A0.000.000.000.000.150.00
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/A0.05N/A
Total Debt to Capitalization
N/AN/A0.000.000.000.000.050.00
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/A-87.66N/A
Cash Flow to Debt Ratio
N/AN/A-67.38-40.35-53.66-60.49-3.97-67.38
Company Equity Multiplier
-3.86-2.171.041.121.151.121.151.04
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A-1.23-24.56-166.17-11.75-166.17-24.56
Free Cash Flow / Operating Cash Flow Ratio
1.031.121.011.041.031.011.031.01
Cash Flow Coverage Ratio
N/AN/A-67.38-40.35-53.66-60.49-3.97-67.38
Short Term Coverage Ratio
N/AN/A-67.38-40.35-53.66-60.49-53.66-67.38
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/A